These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9093386)

  • 41. Antitumor effect of carboplatin combined with hyperthermia on Ehrlich-ascites tumor in vivo.
    Mizuuchi H; Yoshiga K; Sakurai K; Tsumura M; Takada K
    Anticancer Res; 1996; 16(1):381-7. PubMed ID: 8615640
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Toxicity and antitumoral activity of two new complex compounds of rhenium].
    Natorkhin MI; Stukov AN; Filov VA
    Vopr Onkol; 2002; 48(1):61-2. PubMed ID: 12101569
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A new boron compound (guanidine biboric acid adduct) as an antitumour agent against Ehrlich ascites carcinoma in mice.
    Ghosh P; Sur B; Bag SP; Sur P
    Tumour Biol; 1999; 20(1):44-51. PubMed ID: 9858874
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Organ distribution and pharmacokinetics of titanium after treatment with titanocene dichloride.
    Köpf-Maier P; Brauchle U; Henssler A
    Toxicology; 1988 Oct; 51(2-3):291-8. PubMed ID: 3176032
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human tumour xenografts in nude mice: chemotherapy trials with titanocene dichloride in different dosages.
    Villena-Heinsen C; Friedrich M; Ertan AK; Schmidt W
    Clin Exp Obstet Gynecol; 1998; 25(1-2):5-8. PubMed ID: 9743868
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hydrocortisone protects cycloheximide-challenged mice pretreated with Ehrlich ascites tumour cells or with cell-free Ehrlich ascites tumour fluid.
    Parry EW
    J Comp Pathol; 1990 Oct; 103(3):315-9. PubMed ID: 2258469
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tumor inhibition by metallocenes: antitumor activity of titanocene dihalides (C5H5)2TiX2 (X=F, Cl, Br, I, NCS) and their application in buffered solutions as a method for suppressing drug-induced side effects.
    Köpf-Maier P; Hesse B; Voigtländer R; Köpf H
    J Cancer Res Clin Oncol; 1980; 97(1):31-9. PubMed ID: 7400205
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human tumour necrosis factor-alpha inhibits glucose transport in cultured Ehrlich ascites tumour cells.
    Fung KP; Lam WP; Choy YM; Lee CY
    Life Sci; 1995; 57(1):PL1-6. PubMed ID: 7541099
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibitory effect of hydroxynitrodihydrothymine on the growth of Ehrlich ascites tumor cells.
    Mustea I; Bara A; Comes R; Postescu ID
    Cancer Treat Rep; 1978 May; 62(5):823-7. PubMed ID: 26466
    [No Abstract]   [Full Text] [Related]  

  • 50. Genotoxicity and cytotoxicity of cisplatin treatment combined with anaesthetics on EAT cells in vivo.
    Brozovic G; Orsolic N; Knezevic F; Horvat Knezevic A; Benkovic V; Sakic K; Hrgovic Z; Bendelja K; Fassbender WJ
    Onkologie; 2009 Jun; 32(6):337-43. PubMed ID: 19521121
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The effects of CHIP (Pt IV) on the cytokinetics of Ehrlich ascites carcinoma cells].
    Cao J; Pan QC
    Yao Xue Xue Bao; 1987 Feb; 22(2):93-7. PubMed ID: 3618242
    [No Abstract]   [Full Text] [Related]  

  • 52. Antitumor activity of titanocene dichloride in xenografted human renal-cell carcinoma.
    Köpf-Maier P
    Anticancer Res; 1999; 19(1A):493-504. PubMed ID: 10226588
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-tumour Activity.
    Prog Drug Res; 2016; 71():165-7. PubMed ID: 26939285
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of recombinant human tumor necrosis factor-alpha on Ehrlich ascites tumor growth.
    Terlikowski S; Sulkowska M; Nowak HF
    J Environ Pathol Toxicol Oncol; 2002; 21(1):87-92. PubMed ID: 11934018
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tumor inhibition by ferricenium complexes: systemic effect in vivo and cell growth inhibition in vitro.
    Köpf-Maier P
    Z Naturforsch C Biosci; 1985; 40(11-12):843-6. PubMed ID: 3832667
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Significance of formation of micronuclei in SCC VII murine cells treated with various chemotherapeutic agents].
    Jeremić B; Sibamoto J; Abe M
    Srp Arh Celok Lek; 1996; 124(7-8):169-74. PubMed ID: 9102841
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antitumor activity of titanocene amino acid complexes.
    Köpf-Maier P; Tornieporth-Oetting IC
    Biometals; 1996 Jul; 9(3):267-71. PubMed ID: 8696077
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A comparative study of the cytogenetic and antineoplasmatic effects induced by carboplatin in combination with niacin in human lymphocytes in vitro and in Ehrlich ascites tumor cells in vivo.
    Mylonaki-Charalambours E; Mourelatos D; Kotsis A
    Chemotherapy; 1998; 44(2):121-8. PubMed ID: 9551243
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transplacental passage of titanium after treatment with titanocene dichloride.
    Köpf-Maier P; Brauchle U; Heussler A
    Toxicology; 1988 Mar; 48(3):253-60. PubMed ID: 3344525
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of garlic, Chinese medicinal drugs and amino acids on growth of Erlich ascites tumor cells in mice.
    Choy YM; Kwok TT; Fung KP; Lee CY
    Am J Chin Med; 1983; 11(1-4):69-73. PubMed ID: 6660216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.